Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In recent years, off-label use for weight loss has contributed to GLP-1 RAs shortages, limiting access for patients with diabetes
This medicine has proved its effectiveness and captured the interest of the medical community
Lixisenatide is an exendin-derived GLP-1RA for which PPG lowering is brought about mostly through delayed gastric emptying and reduced glucagon release
Severe kidney disease or dehydration risk GI side effects can lead to dehydration and, in vulnerable patients, acute kidney injury
Although many people need to stay on semaglutide or tirzepatide long-term, some folks can come off these medications
US$ 24.01
US$ 29.37
US$ 29.49
